Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BELLUS HealthParadigm BiopharmaceuticalsCEL-SCICel-SciOxford BioMedica
SymbolTSE:BLUASX:PARNYSEAMERICAN:CVMNASDAQ:CVMLON:OXB
Price Information
Current PriceC$13.99A$1.69$11.54$11.54GBX 539
52 Week RangeBuyN/ABuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price TargetN/AN/A$18.00$18.00GBX 860
% Upside from Price TargetN/AN/A55.98% upside55.98% upside59.55% upside
Trade Information
Market CapC$818.50 million$315.51 million$366.10 million$433.18 million£414.42 million
BetaN/AN/AN/AN/AN/A
Average Volume116,865N/A1,114,9321,114,9326,890,000
Sales & Book Value
Annual RevenueC$35,000.00$3.78 millionN/AN/A£63.59 million
Price / Sales24,042.4188.40N/AN/A6.52
CashflowC$3.17 per shareA$0.51 per shareN/AN/AGBX 45.82 per share
Price / Cash4.423.33N/AN/A11.76
Book ValueC$2.08 per shareA$0.40 per shareN/AN/AGBX 104.50 per share
Price / Book6.724.19N/AN/A0.05
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSC($0.73)A($0.10)N/AN/AGBX (11.60)
Trailing P/E RatioN/AN/A0.000.00N/A
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.21%1.17%N/AN/A10.55%
Current Ratio12.38%66.64%N/AN/A2.21%
Quick Ratio11.99%66.37%N/AN/A1.80%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees10N/AN/AN/A432
Shares Outstanding60.15 million197.81 million36.68 million36.68 million76.89 million
Next Earnings Date5/13/2020 (Estimated)N/A5/12/2020 (Estimated)5/12/2020 (Estimated)N/A
OptionableNot OptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel